Data / Drug companies / Ezetimibe
Ezetimibe: 26 companies and 42 products in the FDA NDC directory
Ezetimibe is listed in the FDA National Drug Code Directory by 26 companies, with 42 products in commercial distribution. 41 of the products (97.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on September 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 26
- Products
- 42
- Generic (ANDA) products
- 41 (97.6%)
- Application numbers
- 14
- Routes
- Oral
- Brand names
- Zetia
- openFDA record search
- api.fda.gov
Companies that list ezetimibe
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 11 | tablet | Generic drugs (ANDA) | July 26, 2022 |
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | July 26, 2022 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | December 23, 2017 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | April 29, 2022 |
| Accord Healthcare Inc. | 1 | tablet | Generic drugs (ANDA) | October 7, 2019 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | September 6, 2018 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet | Generic drugs (ANDA) | June 12, 2017 |
| Ascend Laboratories, LLC | 1 | tablet | Generic drugs (ANDA) | December 23, 2017 |
| Aurobindo Pharma Limited | 1 | tablet | Generic drugs (ANDA) | August 25, 2017 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | July 2, 2017 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | June 12, 2017 |
| Camber Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | July 26, 2022 |
| Glenmark Pharmaceuticals Inc., USA | 1 | tablet | Generic drugs (ANDA) | April 29, 2022 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | June 12, 2017 |
| Macleods Pharmaceuticals Limited | 1 | tablet | Generic drugs (ANDA) | April 29, 2024 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | December 23, 2017 |
| Marlex Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | January 1, 2024 |
| NorthStar Rx LLC | 1 | tablet | Generic drugs (ANDA) | February 1, 2021 |
| Ohm Laboratories Inc. | 1 | tablet | Generic drugs (ANDA) | June 12, 2017 |
| Organon LLC | 1 | tablet | New drug applications (NDA) | June 1, 2021 |
| Orient Pharma Co., Ltd. | 1 | tablet | Generic drugs (ANDA) | June 30, 2022 |
| Quallent Pharmaceuticals Health LLC | 1 | tablet | Generic drugs (ANDA) | August 20, 2022 |
| Safecor Health, LLC | 1 | tablet | Generic drugs (ANDA) | September 2, 2026 |
| ScieGen Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | October 23, 2020 |
| Zydus Lifesciences Limited | 1 | tablet | Generic drugs (ANDA) | August 9, 2017 |
| Zydus Pharmaceuticals USA Inc. | 1 | tablet | Generic drugs (ANDA) | August 9, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 42 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 41 | 97.6% |
| New drug applications (NDA) | 1 | 2.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Dietary Cholesterol Absorption Inhibitor | 42 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.